The following information was taken from the 2006 financial statements of pharmaceutical giant Merck and Co. All dollar amounts are in millions.
Retained earnings, January 1, 2006
$37,980.0
Materials and production expense
6,001.1
Marketing and administrative expense
8,165.4
Dividends
3,318.7
Sales revenue
22,636.0
Research and development expense
4,782.9
Tax expense
1,787.6
Other revenue
2,677.1
Hint: Prepare income statement and retained earnings statement.
(SO 4)
Instructions (a)
After analyzing the data, prepare an income statement and a retained earnings statement for the year ending December 31, 2006.
(b)
Suppose that Merck decided to reduce its research and development expense by 50%. What would be the short-term implications? What would be the long-term implications? How do you think the stock market would react?
E1-12
This information is for Damon Corporation for the year ended December 31, 2010.
Cash received from lenders
$20,000
Cash received from customers
60,000
Cash paid for new equipment
35,000
Cash dividends paid
8,000
Cash paid to suppliers
18,000
Cash balance 1/1/10
12,000
Hint: Prepare a statement of cash flows.
(SO 5)
Instructions •
Prepare the 2010 statement of cash flows for Damon Corporation.
•
Suppose you are one of Damon's creditors. Referring to the statement of cash flows, evaluate Damon's ability to repay its creditors.
E1-13
The following data are derived from the 2006 financial statements of Southwest Airlines. All dollars are in millions. Southwest has a December 31 year-end.
Cash balance, January 1, 2006
$2,280
Cash paid for repayment of debt
607
Cash received from issuance of common stock
260
Cash received from issuance of long-term debt
300
Cash received from customers
9,081
Cash paid for property and equipment
1,399
Cash paid for dividends
14
Cash paid for repurchase of common stock
800
Cash